Market Introduction
Controlling animal health by preventing animal disease epidemic and monitoring animal food supplies is vital to the any economy and safety of the any country's food supply. Breeding of healthy livestock guarantees a safe supply of food and keep selling prices stable. Animal disease epidemic costs the country millions of dollars owing to livestock trade halts, animal slaughters and subsequent disease elimination efforts. For example, in November 2017, Porcine reproductive and respiratory syndrome virus (PRRSV), causes stillborn piglets which costs U.S. farmers an annual $600 million. Animal diseases with human health connection can adversely affect public health, international trade, and the stability of the agricultural sector. Disease free and healthy animals likely to result in safer food supplies, higher farm productivity, reduced environmental impacts, reduced use of antibiotics.
Market Overview and Dynamics
The Asia Pacificanimal healthmarket is expected to reach US$ 27,884.0 Mn in 2027 from US$ 15,471.8 Mn in 2018. The market is anticipated to grow with a CAGR of 6.9% from 2019-2027. Factors driving the market growth includeinitiatives by rise in demand for proteinaceous food. However, the high complexity and cost of animal drug development and approval processesis likely to have a negative impact on market growth.
Key Market Segments
By product, the prescriptionsegment accounted for the largest market share in the Asia Pacificanimal healthmarket in 2018. In terms of animal type, the production animal segment held the largest market share of the animal healthmarket by 2027.
Major Sources and Companies Listed
Some of the major primary and secondary sources for animal healthmarket included in the report are, Centers For Disease Control And Prevention (CDC), Cattle Health and Welfare Group (CHAWG), Japanese Animal Hospital Association (JAHA), Veterinary Public Health Program (VPH), and among others.
Reasons to buy the report
- To understand the animal health market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for animal health market
- Efficiently plan M&A and partnership deals in animal health market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form animal health market
- Obtain market revenue forecast for market by various segments from 2018-2027 in Asia Pacific region.
ASIA PACIFICANIMAL HEALTHMARKET SEGMENTATION
By Product
- Prescription
- Feed additives
- Pharmaceutical
- Vaccines
- Diagnostics
- Non-prescription
- Nutrition/Supplements
- Grooming Products
- Parasiticides
By Animal Type
- Production Animal
- Companion Animal
By Geography
• Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
Company Profiles
- Virbac
- Elanco
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
Asia Pacific Animal Health Market Strategic Insights
Asia Pacific Animal Health Market Report Highlights
| Report Attribute | Details |
| Market size in 2018 | US$ 15,471.8 Million |
| Market Size by 2027 | US$ 27,884.0 Million |
| CAGR (2019 - 2027) | 6.9% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| Asia-Pacific | China, India, Japan, Australia, Rest of Asia-Pacific |
| Market leaders and key company profiles |
|
Asia Pacific Animal Health Market Country and Regional Insights
